Global Rotarix Market Report 2025

Rotarix Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Clinical Indication (Prevention Of Severe Gastroenteritis, Cross-Protection), By Formulation (Liquid Formulation, Lyophilized Formulation), By Distribution Channel (Hospitals, Clinics, Pharmacies)

Rotarix Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Rotarix Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

What Is Covered Under Rotarix Market?

Rotarix refers to a vaccine that is used to prevent rotavirus infections, which can cause severe diarrhea and dehydration in infants and young children. It is used for protecting against rotavirus gastroenteritis, helping to reduce hospitalizations and severe illness associated with the virus.

The main clinical indication of rotarix include prevention of severe gastroenteritis, and cross-protection. Prevention of severe gastroenteritis refers to measures and strategies aimed at reducing the risk of developing or spreading severe gastrointestinal infections caused by viruses, bacteria, or parasites. The various formulations include liquid formulation, and lyophilized formulation and are distributed through several channels such as hospitals, clinics, and pharmacies.

What Is The Rotarix Market Size 2025 And Growth Rate?

The rotarix market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing birth rates, increasing the need for childhood vaccinations, increased funding from institutions, increasing insurance coverage, and increasing health-care expenditures.

What Is The Rotarix Market Growth Forecast?

The rotarix market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a growing population and live births, a growing number of immunity-compromised individuals, an increasing number of rotavirus-related deaths, growing immunization programs, and an increasing prevalence of rotavirus infections. Major trends in the forecast period include technological advancements, innovative formulations, multivalent vaccines, developing new technology, product innovations, and product approvals.

Rotarix Market Size and growth rate 2025 to 2029: Graph

How Is The Rotarix Market Segmented?

The rotarix market covered in this report is segmented –

1) By Clinical Indication: Prevention Of Severe Gastroenteritis; Cross-Protection

2) By Formulation: Liquid Formulation; Lyophilized Formulation

3) By Distribution Channel: Hospitals; Clinics; Pharmacies

What Is Driving The Rotarix Market? Rising Rotavirus-Related Deaths Drive Growth Of The Market

The increasing number of rotavirus-related deaths is expected to propel the growth of the rotarix market going forward. Rotavirus-related deaths refer to fatalities caused by severe dehydration and complications from rotavirus infection, particularly in young children. Increasing rotavirus-related deaths result from low vaccination coverage, limited access to healthcare, poor infrastructure, and inadequate treatment for dehydration. Rotarix is administered orally in two doses to infants, helping to prevent severe rotavirus infections by stimulating the immune system to produce antibodies against the virus. For instance, in August 2024, according to the GOV.UK, a UK-based government agency, the cumulative number of rotavirus laboratory reports in England up to week 21 of 2024 was 7% higher than the 5-season average. Additionally, rotavirus activity in weeks 18 to 21 of 2024 was 28% above the 5-season average and 37% higher compared to the previous 4-week period. Therefore, the increasing number of rotavirus-related deaths is driving the growth of the rotarix market.

What Is Driving The Rotarix Market? Rising Healthcare Expenditure Driving Growth In The Market

The increasing healthcare expenditure is expected to propel the growth of the rotarix market going forward. Healthcare expenditure is the total spending on medical services, healthcare products, and related services, encompassing both public and private investments in treatment, prevention, and healthcare infrastructure. Healthcare expenditure is rising due to the aging population, which increases the demand for medical services, and advancements in medical technology, which drive up the costs of treatments and procedures. Rotarix helps healthcare expenditure by significantly reducing the incidence of rotavirus infections in infants and young children, thereby minimizing hospitalizations, emergency care, and the need for costly treatments associated with severe gastroenteritis, ultimately lowering the overall financial burden on healthcare systems. For instance, in May 2023, according to the Office for National Statistics, a UK-based national statistics organization, UK healthcare expenditure reached approximately $354.88 billion (£283 billion) in 2022, reflecting a nominal increase of 0.7% compared to spending in 2021. Therefore, the increasing healthcare expenditure is driving the growth of the rotarix market.

Who Are The Major Players In The Global Rotarix Market?

Major companies operating in the rotarix market are GlaxoSmithKline plc

What Are The Key Trends Of The Global Rotarix Market? Innovative Developments To Prevent Gastroenteritis

A key trend in the Rotarix market is focusing on developing innovative products such as therapies to prevent gastroenteritis, particularly in infants and young children, by enhancing vaccine efficacy and broadening accessibility to reduce healthcare burdens associated with rotavirus infections. Therapies to prevent gastroenteritis refer to medical treatments or interventions, including vaccines and medications, designed to reduce the risk of infection or mitigate the severity of gastroenteritis, which is inflammation of the stomach and intestines commonly caused by viral, bacterial, or parasitic infections. For instance, in November 2022, GlaxoSmithKline plc., a UK-based pharmaceutical company, received an approval from the U.S. Food and Drug Administration (FDA) for the Rotarix vaccine, aimed at preventing gastroenteritis caused by rotavirus in infants. This innovative presentation eliminates the need for reconstitution, making it more convenient for healthcare providers to administer. Clinical trials have shown that the liquid formulation is non-inferior in immunogenicity and has a comparable safety profile to the previously available lyophilized version.

Regional Analysis For The Global Rotarix Market

North America was the largest region in the rotarix market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotarix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rotarix market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Rotarix Market?

The rotavirus market consists of sales of products including syringes, needles, cold chain equipment, vials and ampoules, and sterilization equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Rotarix Industry?

The rotarix market research report is one of a series of new reports from The Business Research Company that provides rotarix market statistics, including rotarix industry global market size, regional shares, competitors with a rotarix market share, detailed rotarix market segments, market trends and opportunities, and any further data you may need to thrive in the rotarix industry. This rotarix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Rotarix Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The rotarix market covered in this report is segmented –
1) By Clinical Indication: Prevention Of Severe Gastroenteritis; Cross-Protection
2) By Formulation: Liquid Formulation; Lyophilized Formulation
3) By Distribution Channel: Hospitals; Clinics; Pharmacies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled GlaxoSmithKline plc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Rotarix Market Characteristics

    3. Rotarix Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Rotarix Market Trends And Strategies

    5. Rotarix Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Rotarix Growth Analysis And Strategic Analysis Framework

    6.1. Global Rotarix PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Rotarix Market Growth Rate Analysis

    6.4. Global Rotarix Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Rotarix Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Rotarix Total Addressable Market (TAM)

    7. Global Rotarix Pricing Analysis & Forecasts

    8. Rotarix Market Segmentation

    8.1. Global Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Prevention Of Severe Gastroenteritis

    Cross-Protection

    8.2. Global Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Liquid Formulation

    Lyophilized Formulation

    8.3. Global Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Clinics

    Pharmacies

    9. Global Rotarix Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Rotarix Market Regional And Country Analysis

    10.1. Global Rotarix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Rotarix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Rotarix Market

    11.1. Asia-Pacific Rotarix Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Rotarix Market

    12.1. China Rotarix Market Overview

    12.2. China Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Rotarix Market

    13.1. India Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Rotarix Market

    14.1. Japan Rotarix Market Overview

    14.2. Japan Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Rotarix Market

    15.1. Australia Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Rotarix Market

    16.1. South Korea Rotarix Market Overview

    16.2. South Korea Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Rotarix Market

    17.1. Western Europe Rotarix Market Overview

    17.2. Western Europe Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Rotarix Market

    18.1. UK Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Rotarix Market

    19.1. Germany Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Rotarix Market

    20.1. France Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Rotarix Market

    21.1. Eastern Europe Rotarix Market Overview

    21.2. Eastern Europe Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Rotarix Market

    22.1. North America Rotarix Market Overview

    22.2. North America Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Rotarix Market

    23.1. USA Rotarix Market Overview

    23.2. USA Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Rotarix Market

    24.1. Canada Rotarix Market Overview

    24.2. Canada Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Rotarix Market

    25.1. South America Rotarix Market Overview

    25.2. South America Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Rotarix Market

    26.1. Middle East Rotarix Market Overview

    26.2. Middle East Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Rotarix Market

    27.1. Africa Rotarix Market Overview

    27.2. Africa Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Rotarix Market Competitive Landscape And Company Profiles

    28.1. Rotarix Market Competitive Landscape

    28.2. Rotarix Market Company Profiles

    28.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

    29. Global Rotarix Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Rotarix Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Rotarix Market

    32. Recent Developments In The Rotarix Market

    33. Rotarix Market High Potential Countries, Segments and Strategies

    33.1 Rotarix Market In 2029 - Countries Offering Most New Opportunities

    33.2 Rotarix Market In 2029 - Segments Offering Most New Opportunities

    33.3 Rotarix Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Rotarix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Rotarix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: GlaxoSmithKline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Rotarix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Rotarix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Rotarix Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Rotarix Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Rotarix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: GlaxoSmithKline plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Rotarix market?

Rotarix refers to a vaccine that is used to prevent rotavirus infections, which can cause severe diarrhea and dehydration in infants and young children. It is used for protecting against rotavirus gastroenteritis, helping to reduce hospitalizations and severe illness associated with the virus. For further insights on the Rotarix market, request a sample here

How will the Rotarix market drivers and restraints affect the market dynamics? What forces will shape the Rotarix industry going forward?

The Rotarix market major growth driver - Rising Rotavirus-Related Deaths Drive Growth Of The Market. For further insights on the Rotarix market, request a sample here

What is the forecast market size or the forecast market value of the Rotarix market?

The Rotarix market size has grown strongly in recent years. The rotarix market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing birth rates, increasing the need for childhood vaccinations, increased funding from institutions, increasing insurance coverage, and increasing health-care expenditures. The rotarix market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a growing population and live births, a growing number of immunity-compromised individuals, an increasing number of rotavirus-related deaths, growing immunization programs, and an increasing prevalence of rotavirus infections. Major trends in the forecast period include technological advancements, innovative formulations, multivalent vaccines, developing new technology, product innovations, and product approvals. For further insights on the Rotarix market, request a sample here

How is the Rotarix market segmented?

The rotarix market covered in this report is segmented –
1) By Clinical Indication: Prevention Of Severe Gastroenteritis; Cross-Protection
2) By Formulation: Liquid Formulation; Lyophilized Formulation
3) By Distribution Channel: Hospitals; Clinics; Pharmacies For further insights on the Rotarix market,
request a sample here

Which region has the largest share of the Rotarix market? What are the other regions covered in the report?

North America was the largest region in the rotarix market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotarix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Rotarix market, request a sample here.

Who are the major players in the Rotarix market?

Major companies operating in the rotarix market are GlaxoSmithKline plc . For further insights on the Rotarix market, request a sample here.

What are the key trends in the Rotarix market?

Major trends in the Rotarix market include Innovative Developments To Prevent Gastroenteritis. For further insights on the Rotarix market, request a sample here.

What are the major opportunities in the Rotarix market? What are the strategies for the Rotarix market?

For detailed insights on the major opportunities and strategies in the Rotarix market, request a sample here.

How does the Rotarix market relate to the overall economy and other similar markets?

For detailed insights on Rotarix's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Rotarix industry?

For detailed insights on the mergers and acquisitions in the Rotarix industry, request a sample here.

What are the key dynamics influencing the Rotarix market growth? SWOT analysis of the Rotarix market.

For detailed insights on the key dynamics influencing the Rotarix market growth and SWOT analysis of the Rotarix industry, request a sample here.